Published June 2002 | Version Supplemental Material
Journal Article Open

Hid, Rpr and Grim negatively regulate DIAP1 levels through distinct mechanisms

  • 1. ROR icon California Institute of Technology
  • 2. ROR icon Kansas State University
  • 3. ROR icon Heinrich Heine University Düsseldorf

Abstract

Inhibitor of apoptosis (IAP) proteins suppress apoptosis and inhibit caspases. Several IAPs also function as ubiquitin-protein ligases. Regulators of IAP auto-ubiquitination, and thus IAP levels, have yet to be identified. Here we show that Head involution defective (Hid), Reaper (Rpr) and Grim downregulate Drosophila melanogaster IAP1 (DIAP) protein levels. Hid stimulates DIAP1 polyubiquitination and degradation. In contrast to Hid, Rpr and Grim can downregulate DIAP1 through mechanisms that do not require DIAP1 function as a ubiquitin-protein ligase. Observations with Grim suggest that one mechanism by which these proteins produce a relative decrease in DIAP1 levels is to promote a general suppression of protein translation. These observations define two mechanisms through which DIAP1 ubiquitination controls cell death: first, increased ubiquitination promotes degradation directly; second, a decrease in global protein synthesis results in a differential loss of short-lived proteins such as DIAP1. Because loss of DIAP1 is sufficient to promote caspase activation, these mechanisms should promote apoptosis.

Additional Information

© 2003 Nature Publishing Group. Received 21 January 2002; Accepted 11 March 2002; Published online 14 May 2002. Published online: 14 May 2002. We thank members of the Deshaies lab for their assistance with initial ubiquitination assays and S. Kornbluth for providing the Rpr peptide, and for sharing unpublished observations. We also thank P.D. Zamore and members of his lab for providing the Drosophila embryo translation extract and translation protocols. We also thank G.M. Rubin and E. Kwan for the production of the anti-DIAP1 monoclonal antibody and K. White for th6 flies. This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft (MU1168/4-1) to H.-A.J.M. and grants from the Burroughs Wellcome Fund (New Investigator awards in the Pharmacological Sciences), the Ellison Medical Foundation, and a National Institutes of Health grant GM057422-01 to B.A.H. S.J.Y. was supported by a Jane Coffin Childs Postdoctoral fellowship. Correspondence and requests for material should be addressed to H.-A.J.M. or B.A.H.

Attached Files

Supplemental Material - ncb793-s1.pdf

Files

ncb793-s1.pdf

Files (75.4 kB)

Name Size
md5:4e76be0046458c8a3880d9a305591b85
75.4 kB Preview Download

Additional details

Identifiers

Eprint ID
56491
Resolver ID
CaltechAUTHORS:20150408-124714784

Funding

Deutsche Forschungsgemeinschaft (DFG)
MU1168/4-1
Burroughs Wellcome Fund
Ellison Medical Foundation
NIH
GM057422-01
Jane Coffin Childs Postdoctoral fellowship

Dates

Created
2015-04-08
Created from EPrint's datestamp field
Updated
2021-11-10
Created from EPrint's last_modified field